Synthetic Genomics, Inc. Purchases Patent Portfolio From Febit, Inc.
9/18/2012 10:09:59 AM
More...
|
Febit, Inc. Announces Operational Restructuring; Workforce Cut Approximately 60%; Cord F. Staehler, President and CEO Resigns
6/23/2010 6:36:29 AM
More...
|
Febit, Inc. Launches Whole Genome Sequencing Service in Europe
3/23/2010 1:25:49 PM
More...
|
Febit, Inc.'s miRBase 14 Geniom-Biochip Now With 58 Additional New Sequences Available for Cancer Research
3/1/2010 11:03:15 AM
More...
|
Febit, Inc. Launches New Instrument for Targeted NextGen Sequencing With High Sample Throughput at AGBT Conference
2/17/2010 9:54:44 AM
More...
|
The Scientist Magazine Recognizes Febit, Inc.'s HybSelect(TM) Among the Winners of "Top 10 Innovations of 2009"
12/2/2009 2:03:19 PM
More...
|
Kimmel Cancer Center of Thomas Jefferson University to Study Genomics Using Febit, Inc.’s Sequence Capture and microRNA Solutions
12/1/2009 2:15:29 PM
More...
|
Febit, Inc.: MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples
10/13/2009 8:50:06 AM
More...
|
Life Technologies AG and Febit, Inc. Team to Offer New Solution for Targeted Re-sequencing in Large-scale Genomic Studies
9/28/2009 9:51:21 AM
More...
|
Life Technologies (LIFE) and Febit, Inc. Team to Offer New Solution for Targeted Re-sequencing in Large-scale Genomic Studies
9/28/2009 8:51:39 AM
More...
|
|